Insulin treatment of maternal diabetes mellitus and respiratory outcome in late-preterm and term singletons

BMJ Open

Volumn 5, Issue 6, 2015, Pages

  Becquet, Odile ^a,b,c   El Khabbaz, Fares ^a,b,c   Alberti, Corinne ^a,b,c,d   Mohamed, Damir ^a,b,d   Blachier, Audrey ^b   Biran, Valérie ^a,b,c   Sibony, Olivier ^a,b,c   Baud, Olivier ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c PremUp Foundation   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ADULT; APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; CESAREAN SECTION; COHORT ANALYSIS; DISEASE SEVERITY; GESTATIONAL AGE; GLYCEMIC CONTROL; HELLP SYNDROME; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; MOTHER; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; OXYGEN THERAPY; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PREMATURITY; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; VAGINAL DELIVERY; BLOOD; CHEMICALLY INDUCED; EPIDEMIOLOGY; FEMALE; FRANCE; NEONATAL INTENSIVE CARE UNIT; PREGNANCY IN DIABETICS; PRENATAL EXPOSURE; PREVENTION AND CONTROL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; STATISTICS AND NUMERICAL DATA; TERM BIRTH;

ADULT; FEMALE; FRANCE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INFANT, NEWBORN; INSULIN; INTENSIVE CARE UNITS, NEONATAL; PREGNANCY; PREGNANCY IN DIABETICS; PREMATURE BIRTH; PRENATAL EXPOSURE DELAYED EFFECTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; RISK FACTORS; TERM BIRTH;

EID: 84931268690     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-008192     Document Type: Article

References (23)

1. Rubaltelli FF, Bonafe L, Tangucci M, et al. Epidemiology of neonatal acute respiratory disorders. A multicenter study on incidence and fatality rates of neonatal acute respiratory disorders according to gestational age, maternal age, pregnancy complications and type of delivery. Italian Group of Neonatal Pneumology. Biol Neonate 1998;74:7-15.
2. Gouyon JB, Ribakovsky C, Ferdynus C, et al. Burgundy Perinatal Network. Severe respiratory disorders in term neonates. Paediatr Perinat Epidemiol 2008;22:22-30.
3. Hedderson MM, Darbinian JA, Ferrara A. Disparities in the risk of gestational diabetes by race-ethnicity and country of birth. Paediatr Perinat Epidemiol 2010;24:441-8.
4. Yogev Y, Visser GH. Obesity, gestational diabetes and pregnancy outcome. Semin Fetal Neonatal Med 2009;14:77-84.
5. Anna V, van der Ploeg HP, Cheung NW, et al. Sociodemographic correlates of the increasing trend in prevalence of gestational diabetes mellitus in a large population of women between 1995 and 2005. Diabetes Care 2008;31:2288-93.
6. Mitanchez D, Burguet A, Simeoni U. Infants born to mothers with gestational diabetes mellitus: mild neonatal effects, a long-term threat to global health. J Pediatr 2014;164:445-50.
7. Fung GP, Chan LM, Ho YC, et al. Does gestational diabetes mellitus affect respiratory outcome in late-preterm infants? Early Hum Dev 2014;90:527-30.
8. Jones CW. Gestational diabetes and its impact on the neonate. Neonatal Netw 2001;20:17-23.
9. Durnwald CP. Insulin analogues in the treatment of gestational diabetes mellitus. Clin Obstet Gynecol 2013;56:816-26.
10. Hedderson MM, Ferrara A, Sacks DA. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol 2003;102:850-6.
11. Yogev Y, Langer O. Spontaneous preterm delivery and gestational diabetes: the impact of glycemic control. Arch Gynecol Obstet 2007;276:361-5.
12. Ostlund I, Hanson U, Björklund A, et al. Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care 2003;26:2107-11.
13. Wahabi HA, Fayed AA, Alzeidan RA, et al. The independent effects of maternal obesity and gestational diabetes on the pregnancy outcomes. BMC Endocr Disord 2014;14:47.
14. Hansen AK, Wisborg K, Uldbjerg N, et al. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ 2008;336:85-7.
15. De Luca R, Boulvain M, Irion O, et al. Incidence of early neonatal mortality and morbidity after late-preterm and term cesarean delivery. Pediatrics 2009;123:e1064-71.
16. Vignoles P, Gire C, Mancini J, et al. Gestational diabetes: a strong independent risk factor for severe neonatal respiratory failure after 34 weeks. Arch Gynecol Obstet 2011;284:1099-104.
17. McGillick EV, Morrison JL, McMillen IC, et al. Intrafetal glucose infusion alters glucocorticoid signalling and reduces surfactant protein mRNA expression in the lung of the late gestation sheep fetus. Am J Physiol Regul Integr Comp Physiol 2014;307:R538-45.
18. Miakotina OL, Goss KL, Snyder JM. Insulin utilizes the PI 3-kinase pathway to inhibit SP-A gene expression in lung epithelial cells. Respir Res 2002;3:27.
19. Miakotina OL, Dekowski SA, Snyder JM. Insulin inhibits surfactant protein A and B gene expression in the H441 cell line. Biochim Biophys Acta 1998;1442:60-70.
20. Dekowski SA, Snyder JM. The combined effects of insulin and cortisol on surfactant protein mRNA levels. Pediatr Res 1995;38:513-21.
21. Piper JM, Xenakis EM, Langer O. Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetic pregnancies. J Matern Fetal Med 1998;7:148-53.
22. Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol 2002;186:641-50.
23. Bental Y, Reichman B, Shiff Y, et al. Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks' gestation). Pediatrics 2011;128:e848-55.